Concr
PrivateLast Round
Grant
Feb 9, 2024
Total Funding Raised
$4.66M
Company Overview
Concr operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in November 2023.
Concr is a techbio company that provides a predictive modelling platform, FarrSight®, to enhance confidence and foresight about the therapeutic efficacy of existing and emerging cancer drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Concr Comparables
Compare Concr with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VeriSIM Life | 81% | |
| InSilicoTrials Technologies | 80% | |
| Epigene Labs | 79% |
For institutional investors. Book with your work email.
Concr Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 9, 2024 | ||||
| Seed | Nov 29, 2023 | ||||
| Seed | Mar 31, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Concr Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Deep Science Ventures | Seed |
| Cambridge Angels | Seed |
| Cambridge Enterprise | Seed |
| R42 Group | Seed |
| Parkwalk Advisors | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 85% MoM.
- Feb 9, 2024
$1.26M grant awarded by Innovate UK
For institutional investors. Book with your work email.
Concr Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Concr's valuation, stock price, and market status.
Is Concr a public or private company?
Concr is a private company.
What is the current stock price of Concr?
Concr is a private company, so its shares have no public market price. Caplight tracks Concr's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Concr worth (valuation)?
Valuation information for Concr is not publicly available.
Can I buy Concr stock?
Concr shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Concr's last funding round?
Concr's most recent funding round was Grant on February 9, 2024.
Who are the main investors in Concr?
Key investors in Concr include Cambridge Enterprise.
Will Concr IPO soon?
No public IPO plans have been announced for Concr.
How can I track Concr secondary market activity?
Caplight tracks bids, offers, and trades in Concr's shares on secondary markets.